A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is

PubMed Central30

Replication Data for: MORDOR Infant Adverse Event Survey Data

资源简介：

相关数据集